Silexion Therapeutics (SLXN) Stock Price, Quote, News & History

Key Statistics

Open

$0.34

Volume / Avg.

36.97M / 2.19M

Day Range

$0.32 - $0.35

52 Wk Range

0.34 - 46.94

Market Cap

$1.76M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.27%

Days to Cover

Recent Silexion Therapeutics Corp News

Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket

Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other stocks posted notable gains and losses.

Avi Kapoor

Why AeroVironment Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

AeroVironment surged 5.8% premarket after beating Q1 revenue and EPS estimates; Synergy CHC led gainers, while Ribbon Acquisition fell.

Avi Kapoor

Nasdaq Surges 150 Points; US Inflation Rate Slows To 3.4% In July

US stocks rise, Nasdaq up 150 points. Dow up 0.13%, Nasdaq up 0.62%, S&P 500 up 0.35%. IT shares up 1.2%, healthcare down 0.9%. CPI rises 3.4%.

Avi Kapoor

Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

CRWV shares rose in pre-market trading after reporting better-than-expected Q2 results. BAOS, BOXL, DOGZ, DRMA, ZBAO, HYLN, XHLD, VELO, and HRB also saw gains.

Avi Kapoor

Nasdaq Gains 100 Points; Target Earnings Top Views

US stocks mixed, Nasdaq up 0.39% as Dow down 0.03%. Target Corp beats earnings, oil down 2.4% and mortgage applications decline by 2.3%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.43M

Investing Cash Flow (TTM)

-8.00K

Financing Cash Flow (TTM)

11.23M

Free Cash Flow (TTM)

-12.43M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-1.21M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$307.79K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

48.00

Earnings Yield % (TTM)

-5236.97%

Earnings Yield % (FWD)

-581.89%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.01

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$2.23M

Debt to Equity

9.66

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.34

Volume / Avg.

36.97M / 2.19M

Day Range

$0.32 - $0.35

52 Wk Range

0.34 - 46.94

Market Cap

$1.76M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

0.27%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homol...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

SLXN

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

SLXN

ABBV

FAQ

How do I buy Silexion Therapeutics (SLXN) stock?

You can purchase shares of Silexion Therapeutics (NASDAQ:SLXN) through any online brokerage.

View our list of the best stock brokerages

Who are Silexion Therapeutics (SLXN) competitors?

Other companies in Silexion Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Silexion Therapeutics (SLXN) stock?

Silexion Therapeutics has a consensus price target of $405.00.

What is the current price for Silexion Therapeutics (SLXN)?

The stock price for Silexion Therapeutics (NASDAQ: SLXN) is $0.3171 last updated September 15, 2026 at 7:55 PM EDT.

Does Silexion Therapeutics (SLXN) pay a dividend?

There are no upcoming dividends for Silexion Therapeutics.

When is Silexion Therapeutics (NASDAQ:SLXN) reporting earnings?

Silexion Therapeutics does not have any upcoming earnings scheduled.

Is Silexion Therapeutics (SLXN) going to split?

There is no upcoming split for Silexion Therapeutics.

What sector and industry does Silexion Therapeutics (SLXN) operate in?

Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Silexion Therapeutics Corp (SLXN) Stock Price, Quote, News & History

Silexion Therapeutics (SLXN) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Silexion Therapeutics Corp News

Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket

Why AeroVironment Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Nasdaq Surges 150 Points; US Inflation Rate Slows To 3.4% In July

Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Nasdaq Gains 100 Points; Target Earnings Top Views

Financials

Cash Flows

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Silexion Therapeutics (SLXN) stock?

Who are Silexion Therapeutics (SLXN) competitors?

What is the forecast, or price target, for Silexion Therapeutics (SLXN) stock?

What is the current price for Silexion Therapeutics (SLXN)?

Does Silexion Therapeutics (SLXN) pay a dividend?

When is Silexion Therapeutics (NASDAQ:SLXN) reporting earnings?

Is Silexion Therapeutics (SLXN) going to split?

What sector and industry does Silexion Therapeutics (SLXN) operate in?